Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parenteral Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients - a Pilot Feasibility Study

NCT05829317 is registered in ClinicalTrials.gov with Dr. Stephanie Sibley as lead sponsor.

NCT NCT05829317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05829317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parenteral Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients - a Pilot Feasibility Study
Lead sponsor
Dr. Stephanie Sibley
Phase
Phase 4
Overall status
Recruiting
Start date
August 20, 2023
Completion date
July 1, 2028
Enrollment
200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, new onset atrial fibrillation